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Abstract
In this study, we developed a mouse model of type 2 diabetes mellitus (T2DM) using strep-
tozotocin and nicotinamide and identified factors that increase susceptibility of T2DM mice
to infection by Mycobacterium tuberculosis (Mtb). All Mtb-infected T2DM mice and 40% of
uninfected T2DM mice died within 10 months, whereas all control mice survived. In Mtb-
infected mice, T2DM increased the bacterial burden and pro- and anti-inflammatory cyto-
kine and chemokine production in the lungs relative to those in uninfected T2DM mice and
infected control mice. Levels of IL-6 also increased. Anti-IL-6 monoclonal antibody treat-
ment of Mtb-infected acute- and chronic-T2DM mice increased survival (to 100%) and
reduced pro- and anti-inflammatory cytokine expression. CD11c+ cells were the major
source of IL-6 in Mtb-infected T2DM mice. Pulmonary natural killer (NK) cells in Mtb-
infected T2DM mice further increased IL-6 production by autologous CD11c+ cells through
their activating receptors. Anti-NK1.1 antibody treatment of Mtb-infected acute-T2DM mice
increased survival and reduced pro- and anti-inflammatory cytokine expression. Further-
more, IL-6 increased inflammatory cytokine production by T lymphocytes in pulmonary
tuberculosis patients with T2DM. Overall, the results suggest that NK-CD11c+ cell interac-
tions increase IL-6 production, which in turn drives the pathological immune response and
mortality associated with Mtb infection in diabetic mice.
Author Summary
In the current study, we employed an experimentally induced type 2 diabetes mellitus
(T2DM) model in wild type C57BL/6 mice and investigated the immune response to
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Mycobacterium tuberculosis (Mtb) infection.We found that natural killer (NK) and
CD11c+ cell interactions inMtb-infected T2DMmice led to increased IL-6 production,
which drives the pathological immune response and reduces survival ofMtb-infected
T2DMmice.We also found that IL-6 increases inflammatory cytokine production in pul-
monary tuberculosis patients with T2DM. The NK-CD11c+ axis and the IL-6 pathway
may be promising new targets for host-directed therapies aimed at reducing the severity of
immune pathology, which drives morbidity and mortality in those infected by tuberculosis
(TB).The study demonstrates for the first time that NK-CD11c+ cell interactions increase
IL-6-mediated inflammation and reduce survival in T2DMmice infected withMtb. The
NK-CD11c+ cell axis appears to be a promising new target for reducing inflammation and
mortality in tuberculosis patients with type 2 diabetes.
Introduction
Mycobacterium tuberculosis (Mtb) infects one-third of the world’s population and causes
almost 1.3 million deaths per year [1]. Approximately 90% of those infected have a latent
tuberculosis infection and develop protective immunity to contain it; however, but 10% pro-
gressive to active tuberculosis (TB) diseasemonths or years after infection [2]. The risk for pro-
gression to TB disease is increased by acquired factors including human immunodeficiency
virus (HIV) infection, alcoholism, smoking, and diabetes [3].
Developing nations are epicenters of diabetes [4]. Diabetes mellitus alters innate and adap-
tive immune responses and increases the risk of developing active TB [5]. In type 2 diabetes
mellitus (T2DM) patients, there is a reduced association betweenmycobacteria and monocytes;
therefore, phagocytosis via complement receptors is compromised [6,7].Mtb-infected diabetic
mice show delayed priming of the adaptive immune response, which is necessary to restrict
Mtb replication [8]. Hyperactive T-cell responses and increased Th1 and Th17 cytokine pro-
duction are noted in TB patients with type 2 diabetes [9]. Limited information is available
about experimentalmodels used to study the effects of T2DM duringMtb infection. Spontane-
ous T2DM rodent models, such as GK/Jcl rats, have a higher bacterial load and increased
immune pathology than non-diabeticWistar rats after infectionwith aMtb Kurono aerosol
[10]. Furthermore, T2DM guinea pigs are highly susceptible toMtb infection; even non-dia-
betic hyperglycemia exacerbates disease severity [11,12]. However, a detailed understanding of
the protective immune responses in type 2 diabetic hosts duringMtb infection is essential if we
are to develop an adequate prophylactic or therapeutic agent.
In the current study, we employed an experimentally induced T2DMmodel in wild type
C57BL/6 mice and investigated the immune response toMtb infection.We found that natural
killer (NK) and CD11c+ cell interactions inMtb-infected T2DMmice led to increased IL-6
production, which drives the pathological immune response and increasesmortality. We also
found that IL-6 increases inflammatory cytokine production in pulmonary tuberculosis
patients with T2DM.
Results
Development of a mouse T2DM model
A combination of streptozotocin (STZ) and nicotinamide (NA) induces T2DM in mice [8].
STZ (180 mg/kg of body weight) and NA (60 mg/kg of body weight) were administered intra-
peritoneally to C57BL/6 mice three times, with an interval of 10 days between doses. A
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schematic representation of T2DM induction is shown in Fig 1A. After 1 month, mice devel-
oped T2DM, as assessed by measurement of blood glucose and serum insulin levels. Blood glu-
cose levels measured at monthly intervals for up to 8 months in STZ/NA-treated mice were
consistently250 mg/dl (Fig 1B). Blood glucose levels in control mice were 60–125 mg/dl.
To determine whether STZ/NA-treated mice developed insulin resistance, we next mea-
sured serum insulin levels. One and three months after T2DM induction, serum insulin levels
in STZ/NA-treated mice were significantly higher than those in control mice (Fig 1C). Six
months after T2DM induction, serum insulin levels in STZ/NA-treated mice were 4-fold
higher than those in control mice (Fig 1C). Insulin resistance, a characteristic feature of T2DM,
was confirmed by oral glucose tolerance test (OGTT) 6 months after STZ/NA injection (Fig
1D). Furthermore, serum levels of cholesterol, triglyceride, and free fatty acids were elevated by
6 months after STZ/NA treatment (Fig 1E–1G). Dyslipidemia is another characteristic of
T2DM in humans and, combined with demonstrated insulin resistance, confirms the validity
of our mouse T2DMmodel.
Increased bacterial burden and reduced survival of T2DM mice
We next investigated TB defense in T2DMmice by aerosol challenge withMtb as shown in Fig
2A. One and three months post-infection (p.i.), the lung bacterial burden was similar in T2DM
and control mice (Fig 2B). However, by 6 months p.i., lung bacterial burden was significantly
greater in T2DMmice compared to controls (Fig 2B). A similar increase in the bacterial burden
was observed in the spleens and livers of T2DMmice when compared with those of control
mice (data presented in DryadData Repository;doi:10.5061/dryad.qn42t).
Fig 1. Development of a mouse model of T2DM. A. Schematic representation of T2DM induction in C57BL/6 mice.
B. Random blood glucose sampling at monthly intervals for up to 6 months. Data were pooled from three independent
experiments (n = 5 mice per group per experiment). C. Serum insulin levels were measured by ELISA at 1, 3, and 6
months. D. An oral glucose tolerance test (OGTT) was performed at 6 months post-T2DM induction (left panel). Blood
glucose concentrations and the area under the curve are shown (right panel). E to G. Serum cholesterol, triglyceride,
and free fatty acid levels at 1, 3, and 6 months post-induction of T2DM. C to G. Data are representative of two
independent experiments (n = 5 mice per group per experiment). *P < 0.05, **P < 0.01, and ***P < 0.001.
doi:10.1371/journal.ppat.1005972.g001
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Alveolar macrophages are the first immune cells thatMtb encounters in the lung [13]. To
determine whether the increased bacterial growth described above was due to altered antimi-
crobial function of these cells, we isolated alveolar macrophages from control and T2DMmice
(one, three and six months after T2DM induction) and infected them withMtb. The CFUwere
quantified after 5 days.Mtb growth was similar in the alveolar macrophages of control and
T2DMmice after one and three months post induction of T2DM. However, control ofMtb
growth was impaired in alveolar macrophages, six months after the induction of T2DM (Fig
2C). We next determined the survival of uninfected control and T2DMmice and ofMtb-
infected control and T2DMmice. By 10 months p.i. allMtb-infected T2DMmice died, whereas
only 40% of the uninfected T2DMmice and 6.6% of theMtb-infected non-diabeticmice died
(Fig 2D). In contrast, all control mice survived.
Fig 2. Type 2 diabetes increases the bacterial burden and reduces survival of Mtb-infected mice. A. Schematic representation of T2DM
induction and Mtb infection. B. Bacterial burden in lungs at 1, 3, and 6 months p.i. Data are representative of two independent experiments
(n = 5 mice per group). C. Alveolar macrophages from control and T2DM mice (at 1, 3, and 6 months after the induction of diabetes) were
infected with Mtb at a MOI of 1:2.5. After 2 h, macrophages were washed to remove extracellular bacteria and cultured. After 5 days,
intracellular Mtb levels were measured. Data points represent the mean value of three independent experiments. Pooled lung alveolar
macrophages from two mice per group per time point were used for each independent experiment. D. Survival curves for control (black
square), T2DM (red triangle), Mtb-infected control (blue circle), and Mtb-infected T2DM mice (green diamond). Data were pooled from two
independent experiments (n = 7–8 mice per group per experiment). Survival curves were compared using the log rank test (P < 0.001). Data
are expressed as the mean ± SE. *P < 0.05, **P < 0.01, and ***P < 0.001.
doi:10.1371/journal.ppat.1005972.g002
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T2DM increases pro- and anti-inflammatory responses during Mtb infection
We next determinedwhether T2DM has any effect on pro- and anti-inflammatory responses
followingMtb infection. Control and T2DMmice were infected withMtb, and after 1 and 6
months the levels of various cytokines and chemokines were measured in lung homogenates by
multiplex (23-plex) ELISA. As shown in Fig 3A, there was a significant increase in both pro-
and anti-inflammatory cytokines and chemokines in theMtb-infected T2DMmice at 1 and 6
months p.i., when compared with either uninfected T2DMmice orMtb-infected control mice.
However, the cytokine and chemokine levels in the lungs at 6 months p.i. were significantly
higher than those at 1 month p.i. The levels of inflammatory cytokines (IL-6, IFN-γ, TNF-α,
IL-1β) and chemokines (MCP-1) in whole-lung homogenates from T2DMmice were signifi-
cantly higher than those in homogenates fromMtb-infected control mice or uninfectedT2DM
mice (Fig 3A). In addition, we found that interleukin (IL)-1α, -5, -9, -12 [p40], -12 [p70], and
-13, and G-CSF, GM-CSF, KC, and MIP-1β, in the lung homogenates ofMtb-infected T2DM
mice were significantly higher than those inMtb-infected control mice and uninfectedT2DM
mice at 6 months p.i. (data presented in the DryadData Repository;doi:10.5061/dryad.qn42t).
We also examined expression of various pro- and anti-inflammatory cytokines in whole-lung
tissue using real-time PCR. Similar to the ELISA data, we observed increased expression of
TNF-α, IFN-γ, IL-6, IL-1β, IL-21, IL-23, TGF-β, and IL-10 inMtb-infected T2DMmice (data
presented in the DryadData Repository;doi:10.5061/dryad.qn42t).
Fig 3. Type 2 diabetes increases pro- and anti-inflammatory responses during Mtb infection. Control and T2DM mice were infected with
50–100 CFU of aerosolized Mtb H37Rv. A. At 1 and 6 months p.i., lung homogenates from uninfected control and T2DM, and Mtb-infected
control and T2DM, mice were collected and cytokine and chemokine levels were measured in a multiplex ELISA. Data are representative of two
independent experiments (n = 5 mice per group per experiment). B. At 6 months p.i., lungs from uninfected control and diabetic mice and from
Mtb-infected control and Mtb-infected diabetic mice were isolated and formalin-fixed. Paraffin-embedded tissue sections were prepared, and
hematoxylin and eosin staining was performed. Inflamed lung areas were compared between groups. A representative figure is shown. Data are
representative of two independent experiments (n = 5 mice per group per experiment). Data are expressed as the mean ± SE. *P < 0.05,
**P < 0.01, and ***P < 0.001.
doi:10.1371/journal.ppat.1005972.g003
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Histological analysis revealed significantlymore inflammation throughout the lungs of
Mtb-infected T2DMmice when compared with those ofMtb-infected control mice or unin-
fected T2DMmice (Fig 3B).
IL-6 increases pro- and anti-inflammatory responses and reduces
survival of Mtb-infected T2DM mice
IL-6 is a pleotropic cytokine that regulates both pro- and anti-inflammatory cytokine produc-
tion [14], and it has both protective and pathogenic roles in diabetes [14]. We found that both
pro- and anti-inflammatory cytokine production is dysregulated inMtb-infected T2DMmice
compared to control T2DMmice andMtb-infected control mice. There are conflicting reports
about the role of IL-6 inMtb infection [15,16]. IL-6-deficientmice are susceptible toMtb infec-
tion [15], and IL-6 participates in the induction of type 1 protective T-cell responses after vac-
cination [17]. However, IL-6 is not required to generate specific immune responses toMtb
infection [18]. Thus, we next determinedwhether neutralizing IL-6 affects survival, cytokine
production, or the bacterial burden in T2DMmice. Fig 4A shows a schematic representation of
Mtb infection and anti-IL-6 mAb treatment in T2DMmice. One month after T2DM induction
(acute diabetes), mice were intranasally infected with 50–100 CFU ofMtb. At 6 months p.i.,
the mice were treated with a neutralizing anti-IL-6 mAb, an isotype-matched control mAb, or
PBS. As shown in Fig 4B, 65% (p = 0.05) ofMtb-infected T2DM (acutely diabetic)mice that
received the isotype-matched control mAb or PBS died within 2 months. By contrast, all mice
that received the anti-IL-6 mAb survived.Anti-IL-6 mAb treatment also reduced the bacterial
burden in the lungs (Fig 4C), spleen (1.5 ± 0.8 × 104 vs. 10.5 ± 0.8 × 104 CFU; p = 0.0003), and
liver (1.75 ± 0.25 × 103 vs. 2.7 ± 0.25 103 CFU; p = 0.03). Real-time PCR analysis of lung sam-
ples indicated that anti-IL-6 mAb treatment inhibited expression of IL-17, TNF-α, IL-10, and
TGF-β (Fig 4D) when compared with that in mice treated with the isotype-matched control
mAb or PBS. Histological examination of lung tissue indicated a similar degree of inflamma-
tion in PBS-treated and isotype-matched control antibody-treatedmice with acute T2DM and
infected withMtb (Fig 4E). By contrast, anti-IL-6 mAb treatment significantly reduced inflam-
mation in the lungs ofMtb-infected acute T2DMmice (Fig 4E).
We next determinedwhether neutralizing IL-6 affected survival, cytokine production, or
bacterial burden in mice with chronic T2DM (mice were infected 6 months after T2DM induc-
tion). On the day of infection,mice received the anti-IL-6 mAb, the isotype-matched control
mAb, or PBS (Fig 5A). As shown in Fig 5B, 80% (p = 0.05) ofMtb-infected T2DMmice (chron-
ically diabetic) that received the isotype-matched control mAb or PBS died within 2 months.
By contrast, allMtb-infected chronic T2DMmice that received the anti-IL-6 mAb survived.
Anti-IL-6 mAb treatment also reduced the bacterial burden in the lungs (Fig 5C), spleen
(1.5 ± 0.3 × 104 vs. 4.4 ± 0.8 × 104 CFU; p = 0.01), and liver (0.6 ± 0.6 × 103 vs. 7.8 ± 1.4 × 103
CFU; p = 0.001). Real-time PCR analysis of lung samples indicated that anti-IL-6 mAb treat-
ment of chronically diabeticMtb-infectedmice was associated with reduced expression of IFN-
γ, IL-17, TNF-α, IL-10, and TGF-β (Fig 5D) when compared with that in mice treated with the
isotype-matched control mAb. Histological examination of the lungs suggested a similar degree
of inflammation in PBS-treated and isotype-matched control antibody-treatedmice with
chronic T2DM harboringMtb (Fig 5E). By contrast, anti-IL-6 mAb treatment significantly
reduced inflammation in the lungs ofMtb-infectedmice with chronic T2DM (Fig 5E).
CD11c+ cells are the major source of IL-6 in Mtb-infected T2DM mice
To confirm our finding that IL-6 levels in the lungs ofMtb-infected T2DMmice increased at 6
months p.i., mice were euthanized and lung sections were examined for IL-6 expression by
NK-CD11c+ Cell Crosstalk in Diabetes and Tuberculosis Co-morbidity
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immunohistochemistry (IHC). As shown in Fig 6A and 6B, the mean histology score (H-score)
for IL-6 inMtb-infected diabeticmice was significantly higher than that inMtb-infected con-
trol mice and uninfected diabeticmice. To determine the cellular source of IL-6 inMtb-
infected T2DMmice, we first examined the leukocyte populations by flow cytometry. As
shown in Table 1, the number of CD11c+MHCII+CD103+, CD11c+CD11b+MHCII+,F4/80+
CD64+MHCII+, Ly6G+ neutrophils, and lymphocytes in the lungs ofMtb-infected T2DM
mice at 1 month post-Mtb infectionwas significantly higher than that inMtb-infected non-dia-
beticmice or uninfected T2DM. A similar increase was observed at 6 months p.i.
We next examined the phenotype of IL-6 producing pulmonary cells at 1 and 6 months p.i.
There were no significant differences in the absolute numbers of IL-6-producing Ly6G+
Fig 4. IL-6 increases pro- and anti-inflammatory responses and reduces the survival of Mtb-infected mice with acute type 2 diabetes.
One month after the induction of diabetes (acute diabetes), T2DM mice were infected with 50–100 CFU of aerosolized Mtb. Mice were then
treated with either anti-IL-6 mAb or an isotype-matched control mAb (0.3 mg per mouse, starting 6 months p.i. every 4 days for 2 months). A.
Schematic representation of Mtb infection and anti-IL-6 mAb treatment of T2DM mice. B. Survival of Mtb-infected diabetic mice treated with an
anti-IL-6 mAb or an isotype-matched control mAb. Data were pooled from two independent experiments (n = 3 mice per group per experiment).
Survival curves were compared using the log rank test (P < 0.001). C. Bacterial burden in the lungs. D. Cytokine mRNA expression in the lungs,
expressed as the -fold difference compared with that in untreated diabetic mice. C and D. The lung bacterial burden was determined in four
isotype-matched control antibody-treated mice, and RNA was isolated for subsequent mRNA analysis immediately after death. The remaining
two isotype-matched control antibody-treated mice and the anti-IL-6 antibody-treated mice were sacrificed at 240 days p.i., to determine the lung
bacterial burden and cytokine mRNA levels. T2DM mice and Mtb-infected T2DM mice treated with PBS were subjected to the same procedures.
E. At 6 months p.i., Mtb-infected T2DM mice were treated with either an anti-IL-6 mAb or an isotype-matched control mAb or PBS. Lungs were
isolated and formalin-fixed. Paraffin-embedded tissue sections were prepared, and hematoxylin and eosin staining was performed. Data were
pooled from two independent experiments (n = 3 mice per group per experiment). Data are expressed as mean ± SE. *P 0.05, **P 0.01, and
***P 0.001.
doi:10.1371/journal.ppat.1005972.g004
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neutrophils, B220+IgM+ B cells, CD3+NK1.1-T cells, or CD3-NK1.1+NK cells (Fig 6C). How-
ever, the absolute number of IL-6-producing CD11c+MHCII+CD103+ and CD11c+
CD11b+MHCII+ cells in the lungs of T2DMmice at 1 month afterMtb infection was signifi-
cantly higher than that in the lungs of uninfected T2DMmice (Fig 6C) orMtb-infected control
mice (Fig 6C). As shown in Fig 6C, a similar increase in IL-6-producing CD11c+ cells were
noted in the lungs of T2DMmice at 6 months post-Mtb infection. Although there was an
increased frequency of F4/80+CD64+MHCII+IL-6+ cells in the lungs ofMtb-infected T2DM
Fig 5. IL-6 increases the pro- and anti-inflammatory responses and reduces the survival of Mtb-infected mice with chronic type 2
diabetes. A. Six months after the induction of diabetes, T2DM mice were infected with 50–100 CFU of aerosolized Mtb. Mice were treated with
an anti-IL-6 mAb or an isotype-matched control mAb (0.3 mg per mouse, starting at the time of infection, every 4 days for 2 months). A.
Schematic representation of Mtb infection and anti-IL-6 mAb treatment of T2DM mice B. Survival of Mtb-infected chronically diabetic mice treated
with an anti-IL-6 mAb or an isotype-matched control mAb. Data were pooled from two independent experiments (n = 2 or 3 mice per group per
experiment). Survival curves were compared using the log rank test (P < 0.001). C. Bacterial burden in the lungs. D. Cytokine mRNA expression
in the lungs, expressed as the -fold difference compared with that in untreated diabetic mice. C and D. The bacterial burden in the lungs of four
isotype-matched control antibody-treated mice was determined, and RNA was isolated for mRNA analysis immediately after death. The
remaining isotype-matched control antibody-treated mouse and the anti-IL-6 antibody-treated mice were sacrificed at 240 days p.i., to determine
the bacterial burden in the lung and cytokine mRNA levels. T2DM mice and Mtb-infected T2DM mice treated with PBS were subjected to the
same procedures. E. Six months after T2DM induction, mice were infected with Mtb and treated with either an anti-IL-6 mAb or an isotype-
matched control mAb or PBS. Lungs were isolated and formalin-fixed. Paraffin-embedded tissue sections were prepared, and hematoxylin and
eosin staining was performed. Data were pooled from two independent experiments (n = 2 or 3 mice per group per experiment). Data are
expressed as the mean ± SE. *P 0.05, **P 0.01, and ***P 0.001.
doi:10.1371/journal.ppat.1005972.g005
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mice compared with those of uninfectedT2DMmice at 6 months p.i. (Fig 6C), there was no
significant difference betweenMtb-infected non-diabetic control mice (Fig 6C). Overall, these
results suggest that CD11c+ cells are the major source of IL-6 inMtb-infected T2DMmice. To
further confirm the cellular source of IL-6 at 6 months p.i., we isolated various cell populations
from the pooled spleen, lymph node, and lung cell populations ofMtb-infected control and
T2DMmice by magnetic sorting and measured IL-6 expression by real-time PCR.We found
that CD11c+ cells are the major source of IL-6 (data shown in the DryadData Repository;
doi:10.5061/dryad.qn42t).
Interaction between NK and CD11c+ cells increases IL-6 production in
Mtb-infected T2DM mice
The interaction betweenNK cells and macrophages is crucial for the initiation and amplifica-
tion of early immune responses [19]. We found a significant increase in NK and CD11c+ cell
numbers in the lungs ofMtb-infected T2DMmice (Table 1). To determine whether NK cells
are involved in increased IL-6 production by CD11c+ cells, we first examined lung sections
fromMtb-infected T2DMmice by confocal microscopy. Imaging results at 6 months p.i.
Fig 6. CD11c+CD11b- cells are the major source of IL-6 in Mtb-infected type 2 diabetic mice. Control and T2DM mice were infected with
50–100 CFU of aerosolized Mtb. A. At 6 months p.i., lungs from uninfected control and diabetic mice and from Mtb-infected control and diabetic
mice were isolated and immunohistochemical analysis of IL-6 expression was performed. Representative images of staining patterns in multiple
fields (at 100× and 400×) are shown. B. Histological scores for IL-6 expression in lung sections. C. The frequencies of IL-6-producing lung cell
populations were determined by intracellular flow-cytometry staining at 1 and 6 months p.i. A to C. Data are representative of two independent
experiments (n = 5 mice per group per experiment). Data are expressed as the mean ± SE. *P 0.05, **P 0.01, and ***P 0.001.
doi:10.1371/journal.ppat.1005972.g006
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indicated that more NK cells inMtb-infected T2DMmice were in close proximity to IL-6-pro-
ducing CD11c+ cells than inMtb-infected control mice (Fig 7A and S1 Fig). More importantly,
the result indicates that the marked increase in IL-6 production occurs in the region in which
both NK cells and CD11c+ cells interact. We further determinedwhether the NK and CD11c
+ cell interaction increases IL-6 production by lung mononuclear cells inMtb-infected T2DM
mice. Six months afterMtb infection,mononuclear cells were isolated from the lungs of T2DM
and non-diabetic control mice and some cell populations were depleted of NK cells by mag-
netic separation. Lung mononuclear cells and NK cell-depleted lung mononuclear cells were
cultured with γ-irradiatedMtbH37Rv (γ-Mtb). After 48 h, IL-6 levels in the culture superna-
tants were measured by ELISA and the phenotype of IL-6-producing cells was identified by
flow cytometry. Stimulation with γ-Mtb significantly enhanced IL-6 production by pulmonary
mononuclear cells fromMtb-infected T2DMmice (Fig 7B) when compared with those from
Mtb-infected control mice (Fig 7B). However, depletion of NK cells fromMtb-infected T2DM
pulmonarymononuclear cells led to a significant reduction in IL-6 levels (Fig 7B). Further-
more, we found that the frequency of IL-6+CD11c+MHCII+ and IL-6+CD11b+MHCII+ cells
(Fig 7B) increased significantly after culture ofMtb-infected T2DM pulmonarymononuclear
cells with γ-Mtb. However, depletion of NK cells fromMtb-infected T2DM pulmonarymono-
nuclear cells resulted in a significant reduction in the frequency of IL-6+CD11c+MHCII+ cells
(Fig 7B). By contrast, depletion of NK cells had no effect on the frequency of IL-6+CD11b
+MHCII+ cells (Fig 7B). These results further confirm that CD11c+ cells are a major source of
IL-6 and that NK cells fromMtb-infected T2DMmice increase IL-6 production by CD11c+
MHCII+ cells.
NK cell-activating receptors play an important role in the development of diabetes [20]. We
next examined expression of NK cell-activating receptors inMtb-infectedmice by flow cytom-
etry. Lung CD3-NKp46+ NK cells fromMtb-infected T2DMmice expressed higher levels of
NKG2D (Fig 7C) and DNAM-1 (Fig 7C) than those fromMtb-infected control mice.We then
Table 1. Leukocyte populations in the lungs of control and Mtb-infected mice.
Months Control T2DM Mtb Infection T2DM + Mtb Infection
CD11c+ MHCII+ CD103+ 1 143 ± 66 283 ± 114 868 ± 376 3670 ± 514 * #
6 178 ± 98 211 ± 312 740 ± 253 6660 ± 742 * #
CD11b+ CD11c+ MHCII+ 1 568 ± 262 798 ± 342 3060 ± 797 4740 ± 685 * #
6 778 ± 294 997 ± 385 3170 ±856 5030 ± 768 * #
F4/80+CD64+ MHCII+ 1 2470 ± 562 4200 ± 845 9000 ± 3260 15540 ± 1440 * #
6 1926 ± 429 3940 ± 725 8360 ± 3880 12980 ± 1130 * #
Ly6G+ Neutrophils 1 2539 ± 751.1 7130 ± 1524 106100 ± 14334 85140 ± 8176 * #
6 2307 ± 652.2 5023 ± 1014 51930 ± 7042 76190 ± 7618 * #
NKp46+ CD3- NK cells 1 852 ± 68 962 ± 130 3380 ± 288 3330 ± 263
6 585 ± 72 650 ± 113 3074 ± 242 4310 ± 418 * #
CD3+ NKp46- T cells 1 3120 ± 438 6180 ± 857 15640 ± 2855 27410 ± 2140 * #
6 3790 ± 717 5684 ± 749 11400 ± 2372 14080 ± 3941 * #
B220+ IgM+ cells 1 14270 ± 1252 21350 ± 2586 35505 ± 1834 49109 ± 1463 * #
6 12600 ± 1418 27135 ± 2586 25501 ± 1995 35767 ± 2228 * #
Control and T2DM mice were infected with 50–100 CFU of aerosolized Mtb. At 1 and 6 months p.i., lungs were isolated from uninfected control mice, T2DM
mice, Mtb-infected mice, and Mtb-infected mice with T2DM. The absolute number of leukocytes per 106 total lung cells was determined by flow cytometry.
Data are representative of two independent experiments (n = 5 mice per group). Data are expressed as the mean value ± SE.
*p<0.05, T2DM vs. T2DM + Mtb infection.
#p<0.05, Mtb infection vs. T2DM + Mtb infection.
doi:10.1371/journal.ppat.1005972.t001
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examined the possible role of these activating receptors in stimulating CD11c+ cells to produce
IL-6. At 6 months p.i., lung mononuclear cells fromMtb-infected T2DMmice were cultured
with γ-Mtb in the presence of blockingNKG2D or DNAM-1 mAbs or isotype-matched control
antibodies. The frequency of IL-6-expressing CD11c+MHCII+ cells (Fig 7D) increased signifi-
cantly after culture ofMtb-infected T2DM pulmonarymononuclear cells with γ-Mtb in the
presence or absence of the isotype-matched control antibodies. Blocking the NKG2D (Fig 7D)
Fig 7. Interaction between natural killer and CD11c+ cells increases IL-6 production in Mtb-infected type 2 diabetic mice. T2DM was
induced as described in the Methods. Control and T2DM mice were infected with 50–100 CFU of aerosolized Mtb. A. After 6 months, lungs from
Mtb-infected T2DM mice were isolated and formalin-fixed. Paraffin-embedded tissue sections were analyzed by confocal microscopy to
determine colocalization of NK cells (pink), IL-6+ cells (green), and CD11c+ cells (red). Scale bars, 20 μm (yellow) and 5 μm (white). White
arrows point to IL-6-expressing CD11c+ cells, while yellow arrows point to NK1.1+ natural killer cells. A representative staining pattern from three
independent experiments is shown (n = 3 mice per group per experiment). B. Lung mononuclear cells were isolated by gradient separation and
cultured for 48 h with γ-Mtb (10 μg/ml). Some mononuclear cell populations were depleted of NK cells and cultured with γ-Mtb. The frequency of
IL-6-expressing CD11c+ cells was determined by intracellular flow cytometry, and IL-6 levels in culture supernatants were measured by ELISA.
C. Expression of NKG2D and DNAM-1 by lung NK cells was determined by flow cytometry. D. Lung mononuclear cells were isolated as described
in the methods section and cultured for 48 h with γ-Mtb in the presence or absence of blocking NKG2D or anti-DNAM-1 neutralizing antibodies or
an isotype-matched control antibody. The frequency of IL-6+ CD11c+ cells was determined by intracellular staining, and IL-6 levels in culture
supernatants were measured by ELISA. B to D. Data points represent the mean values from three independent experiments. Pooled lung
mononuclear cell populations from two mice per group were used for each independent experiment. E. CD3-NK1.1+ and CD11C+ cells from
pooled spleen, lymph node, and lung cells from Mtb-infected control and T2DM mice were isolated by magnetic selection and cultured (one NK
cell and four CD11c+ cells) with or without γ-Mtb (10 μg/ml). Some of the -irradiated Mtb H37Rv-cultured cells were cultured in the presence of
blocking antibodies (10 μg/ml) against DNAM-1 or a rat IgG2a κ (the isotype control antibody for the anti-DNAM-1 antibody) or with blocking
antibodies against NKG2D or a rat IgG1 κ (the isotype control antibody for the anti-NKG2D antibody). After 18 h, cell-free culture supernatants
were collected and IL-6 levels were measured by ELISA. *P0.05, **P 0.01, and ***P 0.001.
doi:10.1371/journal.ppat.1005972.g007
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or DNAM-1 (Fig 7D) interaction with CD11c+ cells led to a significant reduction in the fre-
quency of IL-6+CD11c+ cells. Similarly, IL-6 levels in the culture supernatants of cells cultured
with blockingNKG2D (Fig 7D) or DNAM-1 mAbs (Fig 7D) decreased significantly.
To further confirm the above findings, NK cells and CD11c+ cells were isolated from pooled
splenic, lymph node, and lung cells fromMtb-infected control and T2DMmice by magnetic
selection. Autologous NK cells and CD11c+ cells were cultured together at a ratio of 1:4 (1 NK
and 4 CD11c+) in the presence or absence of γ-Mtb and with or without the isotype control or
NKG2D or DNAM-1 blocking antibodies. After 48 h, the culture supernatants were collected
and IL-6 levels were measured by ELISA. Culture ofMtb-infected control orMtb-infected
T2DMmouse NK cells with autologous CD11c+ cells in the absence of γ-Mtb did not induce
IL-6 production. Culture ofMtb-infected control mouse NK cells with autologous CD11c
+ cells in the presence of γ-Mtb resulted in 251.5 ± 65.1 pg/ml IL-6; this increased to
556.9 ± 52.5 pg/ml (p = 0.02) in NK cells and CD11c+ cells fromMtb-infected T2DMmice
(Fig 7E). This increase in IL-6 production by CD11c+ cells was inhibited by anti-DNAM-1 and
anti-NKG2D blocking antibodies (Fig 7E).
Anti-NK1.1 antibody reduces pro- and anti-inflammatory responses and
increases survival of Mtb-infected T2DM mice
The above result indicated that the interaction betweenNK and CD11c+ cells increases IL-6
production inMtb-infected T2DMmice. Therefore, we next determinedwhether depletion of
NK cells with a NK1.1 antibody affected survival, cytokine production, or the bacterial burden
in acute T2DMmice. One month after STZ/NA treatment, acutely diabeticmice were infected
with50–100 CFUMtb. At 6 months p.i., mice were treated with an anti-NK1.1 mAb, an iso-
type-matched control mAb, or PBS (Fig 8A). As shown in Fig 8B, 65% (p<0.05) ofMtb-
infected T2DMmice that received the isotype-matched control mAb or PBS died within 2
months. By contrast, allMtb-infected T2DMmice that received the anti-NK1.1 mAb survived.
Anti-NK1.1 mAb treatment also reduced the bacterial burden in the lungs (Fig 8C), spleen
(1.5 ± 0.86 × 104 vs. 10.5 ± 0.86 × 104 CFU; p = 0.0003), and liver (1.75 ± 0.25×103 vs.
2.75 ± 0.25 × 103 CFU; p = 0.03) by a marginal, but statistically significant, amount. Real-time
PCR analysis of lung samples indicated that anti-NK1.1 mAb treatment of acutely diabetic
Mtb-infectedmice was associated with significantly lower levels of IL-6, TNF-α, IL-10, and
TGF-β (Fig 8D) expression than those observed in mice treated with the isotype-matched con-
trol mAb. Histological examination of lung tissue indicated a similar degree of inflammation in
PBS-treated and isotype-matched control antibody-treatedmice with acute T2DMmice and
Mtb (Fig 8E). By contrast, anti-NK1.1 mAb treatment significantly reduced inflammation in
the lungs ofMtb-infectedmice with acute T2DM (Fig 8E).
IL-6 increases pro-inflammatory cytokine production in T2DM patients
with pulmonary tuberculosis
To determine the relevance of the above findings with respect to humanMtb infection, we
obtained blood from pulmonary tuberculosis patients with or without T2DM and first deter-
mined the frequency of pro-inflammatory cytokine-producingT cells by flow cytometry. The
frequency of IFN-γ- (1.5-fold, p = 0.026, Fig 9A) and IL-2- (2.1-fold, p = 0.002, Fig 9A) produc-
ing cells was significantly higher in the blood of diabetic than in that of non-diabetic pulmo-
nary tuberculosis patients. By contrast, there were no significant differences in the frequency of
TNF-α- and IL-17-producing cells between the two groups. We also cultured whole blood in
the presence of 10 μg/ml purified protein derivative (PPD). After 18 h, the frequency of IFN-γ-,
IL-2-, TNF-α-, and IL-17-producing cells was determined by flow cytometry. As shown in Fig
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9A and 9B, PPD significantly induced expression of IFN-γ, IL-2, TNF-α, and IL-17A. The fre-
quency of IFN-γ- (1.7-fold, p = 0.0002; Fig 9A), IL-2- (2.1-fold, p = 0.0001; Fig 9A and 9B),
TNF-α- (1.6-fold, p = 0.0005; Fig 9A), and IL-17A- (2-fold, p = 0.0004; Fig 9A) producing cells
was significantly higher in diabetic than in non-diabetic pulmonary TB patients. We also
examined whether neutralizing the IL-6 receptor affected PPD-induced changes in the fre-
quency of IFN-γ-, IL-2-, TNF-α-, and IL-17A-producing cells in pulmonary TB patients with
T2DM. As shown in Fig 9B, the anti-IL-6 antibody significantly reduced the frequency of IFN-
γ- (1.7-fold, p = 0.0005), IL-2- (2.2-fold, p = 0.009), TNF-α- (6.6-fold, p = 0.0005), and IL-17A-
Fig 8. Anti-NK1.1 antibody reduces pro- and anti-inflammatory responses and increases survival of Mtb-infected type 2 diabetic mice.
One month after STZ/NA treatment, T2DM mice were infected with 50–100 CFU of aerosolized Mtb H37Rv. Mice were then treated with an anti-
NK1.1 mAb or an isotype-matched control mAb (0.3 mg per mouse, starting at 6 months p.i., every 4 days for 1 month). A. Schematic
representation of Mtb infection and anti-NK1.1 mAb treatment of T2DM mice. B. Survival of Mtb-infected diabetic mice treated with an anti-NK1.1
mAb or an isotype-matched control mAb. Data were pooled from two independent experiments (n = 3 mice per group per experiment). Survival
curves were compared using the log rank test (P < 0.001). C. Bacterial burden in the lungs. D. Cytokine mRNA expression in the above lung
samples, expressed as -fold differences compared with that in untreated diabetic mice. C and D. The bacterial burden in the lungs of four
isotype-matched control antibody-treated mice was examined, and RNA was isolated for subsequent mRNA analysis immediately after death.
The remaining two isotype-matched control antibody-treated mice and anti-NK1.1 antibody-treated mice were sacrificed after 240 days p.i., to
determine the bacterial burden in the lung and cytokine mRNA levels. T2DM mice and Mtb-infected T2DM mice treated with PBS were subjected
to the same procedures. E. At 6 months p.i., Mtb-infected T2DM mice were treated with either an anti-NK1.1 mAb or an isotype-matched control
mAb or PBS. Lungs were isolated and formalin-fixed. Paraffin-embedded tissue sections were prepared, and hematoxylin and eosin staining
was performed. Data were pooled from two independent experiments (n = 3 mice per group per experiment). Data are expressed as the
mean ± SE. *P 0.05, **P 0.01, and ***P 0.001.
doi:10.1371/journal.ppat.1005972.g008
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(3.3-fold, p = 0.0005) producing cells when compared with the isotype-matched control anti-
body. However, the anti-IL-6 antibody had no effect on the frequency of cytokine-producing
cells in healthy volunteers (Fig 9C).
Discussion
In this study, we investigated the immune response of mice toMtb infection following the
induction of T2DM. Diabeticmice were found to have increased lung bacterial burden and
mortality compared to non-diabetic controls. Alveolar macrophages from T2DMmice were
Fig 9. IL-6 drives increased pro-inflammatory cytokine production in type 2 diabetic patients with pulmonary tuberculosis. Blood was
obtained from 20 diabetic pulmonary tuberculosis patients (DM) and from 20 non-diabetic pulmonary tuberculosis patients (NDM). Whole blood
was stimulated or not (UNS) with 10 μg/ml PPD. A. The frequency of IFN-γ-, TNF-α-, IL-17-, and IL-2-producing CD4+ T cells was determined by
flow cytometry. B and C. In some wells, cells from pulmonary tuberculosis patients with T2DM or cells from healthy volunteers were cultured in
the presence of anti-IL-6 receptor neutralizing antibodies or isotype-matched control antibodies (2.5 μg/ml). After 18 h, the frequency of IFN-γ-,
IL-2-, TNF-α-, and IL-17-producing cells was determined by flow cytometry. B. Pulmonary tuberculosis patients with T2DM. C. Healthy
volunteers. Data are expressed as the mean ± SE. *P 0.05, **P 0.01, and ***P 0.001.
doi:10.1371/journal.ppat.1005972.g009
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more permissive toMtb growth ex vivo compared to non-diabetic controls, indicating an
impairment of innate antimicrobial function.Multiplex cytokine and chemokine data and real-
time PCR analysis ofMtb-infected T2DM lungs also demonstrated significantly higher expres-
sion of genes encoding pro- and anti-inflammatory cytokines than in lungs from uninfected
T2DM and infected non-diabetic control mice. Neutralization of IL-6 increased the survival of
allMtb-infected T2DMmice, reduced the bacterial burden, and reduced cytokine production.
We found that CD11c+ cells were the major source of IL-6 inMtb-infected T2DMmice. IL-6
production by CD11c+ cells was further enhanced by NK cells. We also found that IL-6
enhances inflammatory cytokine production in pulmonary tuberculosis patients with T2DM.
Limited information is available about protective immune responses in type 2 diabetic hosts
duringMtb infection.Our results suggest that the NK-CD11c+ cell interaction increases IL-6
production, which drives the pathological immune response and reduces survival ofMtb-
infected T2DMmice.
Chemically induced type 1 diabetes (T1DM) models are widely used in research, and mice
with STZ-induced insulin deficiencydevelop susceptibility to TB [8]. Approximately 90% of
people living with diabetes have T2DM, making it by far the most prevalent form of diabetes in
TB patients [21]. It is therefore important to employ T2DMmodels for mechanistic studies of
this dual burden. Different approaches have been used to model T2DM in animals, including
the combination of high-fat diet with low to intermediate doses of STZ [22]. Some approaches
require relatively long periods of time to exhibit all of the major features of the disease and
some fail to replicate persistent hyperglycemia [23]. This is an important limitation since the
vascular and renal complications of diabetes only develop after prolonged hyperglycemia, and
related mechanisms may drive at least some features of diabetic immunopathy [24]. In the cur-
rent study, we induced T2DM in mice using STZ and NA, which resulted in sustained hyper-
glycemia for up to 8 months. After 6 months, T2DMmice showed significantly elevated blood
cholesterol and triglyceride levels. These findings suggest that our model can be used to investi-
gate TB defenses in the setting of acute or chronic T2DM.
ExperimentalMtb infection has been investigated in other animal models of T2DM. Suga-
wara et al. [10] reported that GK/Jcl rats, which spontaneously develop T2DM, have a higher
bacterial load and more severe immune pathology than non-diabeticWistar rats at 5–12 weeks
after infectionwithMtb Kurono. Expression of mRNA encoding several cytokines, including
IFN-γ, TNF-β, and IL-1β, was higher inWistar rats at 1 and 3 weeks p.i., but higher in GK/Jcl
rats by 12 weeks p.i. Podell et al. [11] reported increased TB susceptibility in guinea pigs with
T2DM induced by low dose STZ plus a high-fat, high-sucrose diet. The guinea pig TB pheno-
type was characterized by an increased bacterial burden, more severe immune pathology,
increased cytokine expression, and increasedmortality. The results of TB studies using the rat
and guinea pig T2DMmodels, the mouse T2DMmodel presented here, and the mouse T1DM
model [8] differ in some aspects; however, all show impaired control ofMtb replication, more
severe immune pathology, and increased expression of multiple cytokines. TB in diabetic peo-
ple is associated with increased sputum smear positivity at the time of diagnosis (a surrogate
marker for higher bacterial burden), increased radiographic severity of disease, increasedmor-
tality (reflecting increased immune pathology), and increased expression of several nominally
protective cytokines [8,9,25,26]. These similarities support the relevance of our T2DMmouse
model to the interaction betweenTB and diabetes in people.
We found that C57BL/6 mice with STZ/NA-induced T2DM exhibited increased expression
of pro- and anti-inflammatory cytokine genes, including IL-6, afterMtb infection. IL-6 is a
pleiotropic cytokine that has both protective and pathogenic roles in diabetes [14]. There are
conflicting reports about the role of IL-6 inMtb infection [15,16]. IL-6 contributes to vaccine-
induced protective immunity in mice [17], and IL-6 knockout mice are highly susceptible to
NK-CD11c+ Cell Crosstalk in Diabetes and Tuberculosis Co-morbidity
PLOS Pathogens | DOI:10.1371/journal.ppat.1005972 October 26, 2016 15 / 24
Mtb [15]. By contrast, IL-6 produced by macrophages infected withMtb in vitro selectively
inhibits macrophage responses to IFNγ, thereby contributing to the survival of mycobacteria
[27]. Correspondingly, IL-6 neutralization increases IFN-γ-mediated killing of intracellular
Mtb by inducing autophagy [28]. In human TB patients, IL-6 is implicated in the pathogenesis
of the immune reconstitution inflammatory syndrome [29,30]
We found that in vivo neutralization of IL-6 conferred a survival benefit and was associated
with a reduced bacterial burden in the lung and pro-inflammatory cytokine expression inMtb-
infectedmice with acute or chronic T2DM; however, it did not alter the hyperglycemic status
of the mice.We also found that CD4+ cells from TB patients with T2DM produced signifi-
cantly elevated levels of Th1 and Th17 cytokines, and that this was inhibited by neutralizing
IL-6. A variety of hematopoietic and non-hematopoietic cells produce IL-6, and we found that
CD11c+ cells were the major source of IL-6 inMtb-infected T2DMmice. IL-6 production was
enhanced by the interaction betweenNKG2D and DNAM-1 and the corresponding ligands on
CD11c+ cells. These results suggest that IL-6 produced during the NK-CD11c+ interaction
may be a key factor that drives the damaging immune pathology in diabetic hosts infected by
TB. Of note, increased expression of activation markers by unstimulated myeloid cells from
diabetic individuals has been documented [31].
NK cells are prominent components of the innate immune system and play a central role in
resistance to microbial pathogens. NK cells protect against viruses, parasites, and bacteria,
includingMtb, by destroying infected cells and secreting cytokines that shape the adaptive
immune response [32–34]. NK cells interact with antigen-presenting cells and T cells, and are
involved in one or more stages of immune-mediated attack. Abnormalities in the frequency
and activity of NK cells have been describedboth in animal models and in patients with diabe-
tes. By contrast, depletion of NK cells prevents the development of diabetes [35,36]. In TB
patients with T2DM, altered CD8+ and NK cell function leads to enhanced pathology [37].
In conclusion, we found that hyperactive NK cells interact with CD11c+ cells to amplify the
IL-6-mediated inflammatory immune response in TB. Our data suggest that NK cell-mediated
IL-6 production by CD11c+ cells is responsible for driving hyperinflammation and increased
mortality in T2DMmice infected withMtb. The mechanism that underlies NK cell hyperacti-
vation in T2DMmice remains unknown, but NK cell activation was recently reported to be an
upstream event in T2DM pathogenesis [38]. The NK-CD11c+ axis and the IL-6 pathway may
be promising new targets for host-directed therapies aimed at reducing the severity of immune
pathology, which drives morbidity and mortality in those infected by TB.
Methods
Animals
Specific pathogen-free female wild-typeC57BL/6 mice (4 to 6 weeks old) were purchased from
Jackson Laboratory and housed at the animal facility at the University of Texas Health Science
Center at Tyler. All animal experiments were approved by the Institutional Animal Care and
Use Committee of the University of Texas Health ScienceCenter at Tyler.
Blood donors
Bloodwas obtained from 20 healthy controls, 20 pulmonary tuberculosis patients, and 20 pul-
monary tuberculosis patients with type T2DM. All subjects were HIV-seronegative with cul-
ture-proven pulmonary tuberculosis who had received anti-tuberculosis therapy for< 1 week.
Acid-fast stains of sputum samples were positive for all patients. Type 2 diabetes patients had
HbA1c levels> 6.5% and random blood glucose levels> 200 mg/dl.
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Ethics statement
All human studies were approved by the Institutional ReviewBoard of the National Institute of
Research in Tuberculosis (NCT01154959), Chennai, India, and informedwritten consent was
obtained from all participants. All animal studies were approved by the Institutional Animal
Care and Use Committee of the University of Texas Health ScienceCenter at Tyler (Protocol
#533). All animal procedures involving the care and use of mice were undertaken in accordance
with the guidelines of the NIH/OLAW (Office of Laboratory AnimalWelfare).
Antibodies and other reagents
PE-conjugated anti-IL-6 (eBioscience), FITC-conjugated anti-CD3 (Tonbo Biosciences), PE-
conjugated anti-NKp46 (BioLegend), PE-cy7 anti-NKG2D (eBioscience), and APC-anti-
DNAM-1 (eBioscience)were used for flow cytometry. Antibodies used for the in vivo neutrali-
zation experiments were purchased from BioXcell (mouse anti-IL-6 [MP5-20F3], anti-NK1.1,
and isotype controls [rat IgG1 and mouse IgG2a antibodies]). The NKG2D and DNAM-1
blocking antibodies were obtained from eBioscience. STZ and NA were obtained from Sigma
Chemicals. Anti-CD11c, anti-IL-6, anti-NK1.1, secondary antibodies (goat anti-hamster
IgG-Alexa 568, donkey anti-rat-Alexa 488, and goat anti-rabbit-Alexa 647), and DAPI were
obtained from Life Technologies and used for confocal microscopy. γ-irradiatedMtbH37Rv
(γ-Mtb) was obtained from BEI Resources. Highly purifiedmouse recombinant IL-6 with a
specific activity of 1 108 units/mg was purchased from BioLegend (Bedford,MA).
Induction of type 2 diabetes
T2DM was induced by combined administration of STZ and NA. STZ was dissolved in a 50
mM citric acid buffer and administered (180 mg/kg of body weight) intraperitoneally three
times, with an interval of 10 days between doses. NA was dissolved in saline and administered
intraperitoneally (60 mg/kg of body weight) 15 min before STZ. Mice were fasted for 16 h
before the STZ and NA injections. Blood glucose was measured using a glucometer at weekly
intervals for up to 8 months. Mice were considered diabetic if their blood glucose was> 250
mg/dl. Control mouse blood glucose levels were always between 80 and 100 mg/dl.
Measurement of serum insulin concentrations
Serum insulin levels in fasting (16 h) control and diabeticmice were measured using a Merco-
dia Ultrasensitive Insulin ELISA Kit (Mercodia AB Uppsala, Sweden).
Measurement of serum lipid profiles
Serum free fatty acids, cholesterol, and triglyceride levels were measured using either a fluoro-
metric or colorimetric assay (Cayman Chemicals, USA), according to the manufacturer’s
instructions.
Oral glucose tolerance test (OGTT)
OGTTs were performed in control and diabeticmice after fasting (16 h). A glucose solution
(2.0 g/kg) was given orally. Blood glucose concentrations were measured 30 min before and 15,
30, 60, and 120 min after administration.
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Isolation of mouse alveolar macrophages (AMs) and infection with Mtb
H37Rv
Murine AMs were isolated from control and T2DMmice by bronchoalveolar lavage at 1 and 6
months post-induction of diabetes. Briefly, mice were euthanized by CO2 asphyxiation. The
trachea was then cannulated following a midline neck incision, and the lungs were lavaged five
times with 1.0 ml of ice cold PBS. Alveolar cells were separated from the lavage fluid by centri-
fugation at 1800 RPM for 10 min. Alveolar cells were plated (on plastic) to permit adherence of
alveolar macrophages and subsequent removal of non-adherent NKT and T lymphocytes by
washing three times with normal PBS. Adherent cells were resuspended in RPMI-1640. Highly
purifiedAMs were used to determine whether reduced growth ofMtb was due to dysfunctional
AMs. Alveolar cells were plated in 96-well tissue culture plates at a density of 2 ×105/100 μl/
well, incubated for 24 h at 37°C in 5% CO2, and washed three times with antibiotic-free RPMI-
1640. Around 98% of the cells expressed CD11c, as determined by flow cytometry. AMs were
infected withMtbH37Rv at a MOI of 1:2.5 (2.5Mtb to 1 macrophage). This MOI was based on
the viability of AMs at different MOIs for up to 7 days p.i. More than 90% of AMs were viable
at this MOI. Cells were incubated for 2 h at 37°C in a humidified 5% CO2 atmosphere, washed
to remove extracellular bacilli, and cultured in RPMI 1640 containing 10% heat-inactivated
human serum. To quantify the intracellular growth ofMtbH37Rv, infectedAMs were cultured
for 5 days after which the supernatant was aspirated and AMs were lysed. Bacterial suspensions
in cell lysates were ultrasonically dispersed, serially diluted, and plated in triplicate on 7H10
agar. The number of colonies was counted after 3 weeks.
Aerosol infection of mice with Mtb H37Rv
Before infectingmice withMtbH37Rv, bacteria were grown in liquid medium to the mid-log
phase and then frozen in aliquots at -70°C. Bacterial counts were determined by plating on
7H10 agar supplemented with oleic albumin dextrose catalase (OADC). For infection, bacterial
stocks were diluted in 10 ml of normal saline (to 0.5 ×106 CFU [colony forming units]/ml, 1
×106 CFU/ml, 2 ×106 CFU/ml, and 4 × 106 CFU/ml) and placed in a nebulizer within an aero-
sol exposure chamber custommade by the University of Wisconsin. In preliminary studies,
groups of three mice were exposed to the aerosol at each concentration for 15 min. After 24 h,
mice were euthanized and homogenized lungs were plated on 7H10 agar plates supplemented
with OADC. CFUs were counted after 14–22 days of incubation at 37°C. The concentration
that deposited ~75–100 bacteria in the lung during aerosol infectionwas used for further
studies.
Neutralization of IL-6
For some experiments,mice were treated with neutralizing anti-IL-6 antibodies. For the first
set of experiments, conducted 1 month after the induction of T2DM, mice were challenged
with aerosolizedMtb. At 6 months p.i., mice received 0.3 mg of anti-IL-6 mAb (BioXcell) or
isotype-matched control Ab (rat IgG1) intravenously every 4 days for up to 2 months. For the
next set of experiments, conducted at 6 months after the induction of T2DM, mice were
infected withMtbH37Rv. On day “0” of infection,mice received 0.3 mg of anti-IL-6 or isotype
control Ab intravenously every 4 days for up to 2 months.
Depletion of NK1.1+ cells
Onemonth after the induction of T2DM, mice were infected with aerosolizedMtb. On day “0”
of infection,mice received 0.3 mg of anti-NK1.1 mAb or isotype control Ab intravenously
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every 4 days for up to 1 month. Previously, we used the same anti-NK1.1 (PK136) antibody to
deplete 95% of the NK1.1 cells [34].
Isolation and culture of lung mononuclear cells
Lungs fromMtb-infectedmice were mechanically homogenized and filtered through a 70 μm
cell strainer. Cells were washed twice, and mononuclear cells were isolated from lung single-
cell suspensions using a one-step gradient separation method (GE Healthcare), according to
the manufacturer’s instructions. Somemononuclear cell populations were depleted of NK cells
by positive selection using antibody-labeledmagnetic beads (Miltenyi Biotech), according to
the manufacturer’s instructions. Lung mononuclear cells and NK cell-depletedmononuclear
cells were seeded in 12-well culture plates (1 × 106 cells per well) and cultured with γ-Mtb.
After 48 h, cells were harvested and IL-6 expression was measured by intracellular flow cytom-
etry. Supernatants were also collected to measure IL-6 levels by ELISA.
Isolation of CD11c+ cells and NK cells
Single-cell suspensions of pooled lung, lymph node, and murine splenocytes were prepared.
CD11c+ cells were isolated by positive selectionwith magnetic beads (Miltenyi Biotec) conju-
gated to anti-CD11c; positively selected cells comprised> 96% CD11c+ cells, as measured by
flow cytometry. NK cells were isolated by negative selection using kits obtained fromMiltenyi
Biotec. Isolated cells comprised> 97% CD3-NK1.1+ cells, as measured by flow cytometry.
Flow cytometry and intracellular staining
After the mice were euthanized, the lungs were perfusedwith 5 ml of PBS via the right ventri-
cle. Lungs were mechanically homogenized and passed through a 70 μm cell strainer. The
remaining red blood cells were lysed using BD Pharm Lyse (BD Biosciences). Surface staining
to identify leukocyte populations was then performed. For IL-6 intracellular staining, cells
(106/ml) were suspended in RPMI 1640 containing 10% FBS and brefeldin A (5 μg/ml), placed
in 24-well culture plates, and stimulated with LPS (1 μg/ml), and incubated for a further 4 h at
37°C to allow intracellular accumulation of cytokines. Cells were then permeabilizedwith 0.1%
saponin and stained for intracellular IL-6. The cells were washed, resuspended in FACS buffer,
and analyzed by flow cytometry using a FACS Calibur flow cytometer.
Culture of human blood cells and intracellular cytokine staining
Whole bloodwas diluted 1:1 with RPMI-1640 medium and cultured in 12-well plates
(0.5 × 106 cells/well) in RPMI 1640 containing penicillin/streptomycin (100 U/100 mg/ml), L-
glutamine (2 mM), and HEPES (10 mM) (Invitrogen, Carlsbad, CA) in the presence or absence
of a PPD (10 μg/ml) at 37°C in a humidified 5% CO2 atmosphere. In some cases, an IL-6R neu-
tralizing Ab (2.5 μg/ml) was added to the culture. Brefeldin A (10 μg/ml) was added to the cul-
tures 2 h before the termination of the cultures (total culture time, 6 h). Cells were washed, and
red blood cells were lysed with lysis buffer. The cells were fixed using Cytofix/Cytoperm buffer
(BD Biosciences) and cryopreservedat -80°C. Intracellular staining for IFN-γ, TNF-α, IL-2,
and IL-17A was performed as previously described [9].
Multiplex ELISA to measure cytokine and chemokine levels in lung
homogenates
Mouse multiplex ELISA kits (23-Plex kits, Bio-Rad) were used to measure chemokine and
cytokine levels, according to the manufacturer’s instructions.
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Real-time PCR measurement of cytokine mRNA expression
Total RNA was extracted from lung leukocytes or lung tissue as describedpreviously [39].
Total RNA was reverse transcribedusing the Clone AMV First-Strand cDNA synthesis kit
(Life Technologies). Real-time PCR was performed using the Quantitect SYBR Green PCR kit
(Qiagen) in a sealed 96-well microtiter plate (Applied Biosystems) on a spectrofluorometric
thermal cycler (7700 PRISM; Applied Biosystems). PCR reactions were performed in triplicate
as follows: 95°C for 10 min, followed by 45 cycles of 95°C for 15 s, 60°C for 30 s, and 72°C for
30 s. All samples were normalized to the amount of β-actin/GAPDH transcript present in each
sample. The primers used in the study are listed in Table 2.
Histology and IHC
Lungs were inflated and fixed in 10% neutral buffered formalin (v/v) for 24 h. Tissue sections
were stained with hematoxylin and eosin. A semi-quantitative analysis was performed using a
score from 0 (no inflammation) to 4 (severe inflammation) for each of the following criteria:
alveolar wall inflammation, alveoli destruction, leukocyte infiltration, and perivascular inflam-
mation. Immunostaining of thin paraffin-fixed lung sections was performed using antibodies
against IL-6 according to the manufacturer’s instructions (Novus Biologicals, USA). Unstained
sections of formalin-fixed lung tissue from paraffin blocks were first deparaffinized and sub-
jected to antigen retrieval in a citrate buffer at 95°C, as previously described. Endogenous per-
oxidase activity was blocked by addition of 3% H2O2 in methanol. Slides were incubated in 3%
BSA in TBS for 2 min, after which primary antibodies were added at predetermined dilutions
in TBS-Tween + 1% BSA (1:100) for 1 h at 25°C. Sectionswere then washed three times in
TBS-T for 15 min. The IL-6 antigen was detected by IHC and the DAB (DAKO) chromogen,
as previously described. Lung inflammation [40,41] and immunohistochemical readouts were
independently assessed by two investigators as previously described [42]. The H-score was
determined according to the method described by Pirker et al. Briefly, the percentage of cells
with different staining intensities was determined by visual assessment and assigned a score
(1+ for light staining, 2+ for intermediate staining, and 3+ for dark staining) using the ImageJ
IHC profiler. The H-score was calculated using the formula 1 × (% of 1 + cells) + 2 × (% of 2 +
cells) + 3 × (% of 3 + cells).
Table 2. List of primers used in the study.
S. No. Gene Name Mouse Primer Sequences
1 IFN-γ Forward: TCA AGT GGC ATA GAT GTG GAA GAA Reverse: TGG CTC TGC AGG ATT TTC AT G
2 TNF-α Forward: CAT CTT CTC AAA ATT CGA GTG ACA A Reverse: TGG GAG TAG ACA AGG TAC AAC CC
3 IL-17 Forward: CAG ACT ACC TCA ACC GTT CCA C Reverse: TCC AGC TTT CCC TCC GCA TTG A
4 IL-6 Forward: TAC CAC TTC ACA AGT CGG AGG C Reverse: CTG CAA GTG CAT CAT CGT TGT TC
5 IL-23 Forward: CAT GCT AGC CTG GAA GCG ACA T Reverse: ACT GGC TGT TGT CCT TGA GTC C
6 IL-21 Forward: GCC TCC TGA TTA GAC TTC GTC AC Reverse: CAG GCA AAA GCT GCA TGC TCA C
7 IL-1β Forward: CAA CCA ACA AGT GAT ATT CTC CAT G Reverse: GAT CCA CAC TCT CCA GCT
8 IL-22 Forward: CAT GCA GGA GGT GGT GCC TT Reverse: CAG ACG CAA GCA TTT CTC AG
9 IL-12p35 Forward: CTT AGC CAG TCC CGA AAC CT Reverse: TTG GTC CCG TGT GAT GTC T
10 TGF-β Forward: TGA TAC GCC TGA GTG GCT GTC T Reverse: CAC AAG AGC AGT GAG CGC TGA A
11 IL-10 Forward: GGT TGC CAA GCC TTA TCG GA Reverse: ACC TGC TCC ACT GCC TTG CT
12 FoXP3 Forward: CCT GGT TGT GAG AAG GTC TTC G Reverse: TGC TCC AGA GAC TGC ACC ACT T
13 G-CSF Forward: TGC TTA AGT CCC TGG AGC AA Reverse: AGC TTG TAG GTG GCA CAC AA
14 β-actin Forward: CTC TGG CTC CTA GCA CCA TGA AGA Reverse: GTA AAA CGC AGC TCA GTA ACA GTC CG
doi:10.1371/journal.ppat.1005972.t002
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Confocal microscopy
Confocalmicroscopy was performed to colocalize IL-6-producing CD11c+ and NK1.1+ cells
in lung sections. Nonspecific binding was blocked with 1% goat serum in PBS for 30 min. The
slides were then incubated at 4°C overnight with hamster monoclonal anti-CD11c (Abcam),
rabbit polyclonal anti-NK 1.1 (Bioss), and rat monoclonal anti-IL-6 (Novus Bio) antibodies.
Subsequently, the slides were washed thoroughly using 1 × PBS. Then, cells were stained with
the respective secondary antibodies (goat anti-hamster IgG-Alexa 568, goat anti-rabbit-Alexa
647, or donkey anti-rat-Alexa 488; Life Technologies), washed with PBS, and mounted with
Prolong Gold antifade reagent containing DAPI (Life Technologies, USA). The slides were
examined and analyzed under a laser-scanning confocal microscope (Zeiss LSM 510 Meta
laser-scanning confocal microscope).
IL-6 bioassay
The efficacy of in vivo IL-6 neutralization was assessed in a IL-6 bioassay using the 8G2 cell
line (an IL-6-dependent murine hybridoma cell line LS132.8G2) instead of the B9 cell line as
previously described [43].
Statistical analysis
Data analyses were performed using GRAPHPAD PRISM (GraphPad Software, Inc., La Jolla,
CA). The results are expressed as the mean ± SE. For normally distributed data, comparisons
between groups were performed using a paired or unpaired t-test and ANOVA, as appropriate.
Statistically significant differences between two clinical groups were analyzed using the non-
parametricMann–Whitney U-test. Data are deposited in the DryadData Repository:
(doi:10.5061/dryad.qn42t)[44].
Supporting Information
S1 Fig. Natural killer and dendritic cell interaction enhanced IL-6 production inMtb-
infected type 2 diabeticmice. Five control and 5 T2DMmice were infected with 50–100 CFU
of aerosolizedMtbH37Rv. Six months p.i., lungs fromMtb-infected control and T2DMmice
were isolated and formalin-fixed. Paraffin-embedded tissue sections were prepared and confo-
cal microscopy analysis was performed to determineNK (pink), IL-6+ (green) and dendritic
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